Wait, we have a special
offer for you!
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Only Available By Prescription
Top brand choice
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
STRIVERDI RESPIMAT Inhalation Spray is a long-acting beta2-adrenergic agonist indicated for: The long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema (1.1) Important limitations: ? STRIVERDI RESPIMAT is NOT indicated to treat acute deterioration of COPD (1.2) ? STRIVERDI RESPIMAT is NOT indicated to treat asthma (1.2)
How should I use STRIVERDI RESPIMAT? ? The STRIVERDI RESPIMAT inhaler has a slow-moving mist that helps you inhale the medicine. ? Read the step-by-step instructions for using STRIVERDI RESPIMAT at the end of this Medication Guide. ? Use STRIVERDI RESPIMAT exactly as your healthcare provider tells you to use it. ? Use 1 dose (2 puffs) of STRIVERDI RESPIMAT, 1 time each day, at the same time of the day. ? If you miss a dose of STRIVERDI RESPIMAT, take it as soon as you remember. Do not take more than 1 dose (2 puffs) in 24 hours. ? Do not spray STRIVERDI RESPIMAT in your eyes. ? Always use the new STRIVERDI RESPIMAT inhaler that is provided with each new prescription. ? STRIVERDI RESPIMAT does not relieve sudden symptoms of COPD. Always have a rescue inhaler medicine with you to treat sudden symptoms. If you do not have a rescue inhaler medicine, call your healthcare provider to have one prescribed for you. ? Do not stop using STRIVERDI RESPIMAT or other medicines to control or treat your COPD unless told to do so by your healthcare provider because your symptoms might get worse. Your healthcare provider will change your medicines as needed. ? Do not use STRIVERDI RESPIMAT: o more often than prescribed for you, or o with other LABA medicines ? Call your healthcare provider or get emergency medical care right away if: o your breathing problems worsen with STRIVERDI RESPIMAT o you need to use your rescue medicine more often than usual o your rescue inhaler medicine does not work as well for you at relieving your symptoms
What are the ingredients in STRIVERDI RESPIMAT? Active ingredient: Olodaterol Inactive ingredients: water, benzalkonium chloride, edetate disodium, and anhydrous citric acid
Who should not use STRIVERDI RESPIMAT? Do not use STRIVERDI RESPIMAT if you have asthma. What should I tell my healthcare provider before using STRIVERDI RESPIMAT? Tell your healthcare provider about all of your health conditions, including if you: ? have heart problems ? have high blood pressure ? have seizures ? have thyroid problems ? have diabetes ? are pregnant or planning to become pregnant. It is not known if STRIVERDI RESPIMAT can harm your unborn baby. ? are breastfeeding. It is not known if STRIVERDI RESPIMAT passes into your breast milk and if it can harm your baby. ? are allergic to STRIVERDI RESPIMAT or any of its ingredients, any other medicines, or food products. Tell your healthcare
The most common adverse reactions at the recommended dose were nasopharyngitis, dizziness, hypertension, rash and arthralgia. These were usually mild or moderate in intensity.
